Clinical trial
Low, Intermediate, or High Dose Suramin in Treating Patients With…
NCT00002723 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00002723 |
|---|---|
| Title | Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer |
| Official title | A PHASE III STUDY OF THREE DIFFERENT DOSES OF SURAMIN (NSC #34936) ADMINISTERED WITH A FIXED DOSING SCHEDULE IN PATIENTS WITH ADVANCED PROSTATE CANCER |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | SWOG Cancer Research Network Eastern Cooperative Oncology Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | suramin, Suramin |
| Enrollment | 390 |
| Start date | Jan 1, 1996 |
| Primary completion | Aug 1, 2002 |
| Completion | Mar 1, 2008 |
| First posted | Oct 22, 2003 |
| Last update posted | Feb 28, 2013 |
| Countries | South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: